$HCM

$12.04▲ +1.1% YTD

2 SEC 13D/G filings tracked · Last updated Sep 3, 2026

Filing History

News

HCM ▲ +1.1% - HUTCHMED (China) Limited

CP $12.04▲ +1.1%Sep 3, 2026 · ThinkSabio Blog

$HCM - HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy…

News

HCM ▼ -0.9% - HUTCHMED (China) Limited

CP $12.31▲ -0.9%Aug 31, 2026 · ThinkSabio Blog

$HCM - HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patie…